Becton, Dickinson and Co. news

   Watch this stock
Showing stories 1 - 10 of about 41   

Articles published

BDX 140.33 -0.93 (-0.66%)
price chart
Recent cases show that utilitarian functionality is a serious � and common ...
In other words, courts may consider whether alternative product designs are available, and whether the cost or time involved in using an alternative design makes it impractical.
JDRF, BD Expand Diabetes Collaboration to Develop Continuous Glucose ...
Diabetes research organization JDRF and Becton, Dickinson and Company (BD) have extended their existing type 1 diabetes collaboration to include further development of the latter's next-generation continuous glucose-sensing platform.
JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose ...  PR Newswire (press release)
Related articles »  
'Quality' the watchword for Sentry's US picks
Mr. Hearn is also a big fan of Wells Fargo & Co. It is �one of the best run banks in the United States,� he said. It has dramatically increased its share in the mortgage-loan business, and has successfully integrated Wachovia Corp.
Asuragen Grants Armored RNA� Technology License to BD
AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc. announced today that it has granted BD (Becton, Dickinson and Company), a global medical technology company, non-exclusive worldwide rights to incorporate Armored RNA� technology into its in vitro ...
Related articles »  
Inequitable conduct remains a powerful tool for retailers after Therasense
After the Federal Circuit's 2011 decision in Therasense Inc. v. Becton, Dickinson and Co., many practitioners thought that holding patents unenforceable based upon inequitable conduct before the Patent Office was all but dead.
Research and Markets: Life Sciences & Analytical Reagents Market
Biotechnology (life science and analytical) reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading.
Related articles »  
Ezose Sciences Announces Appointment of Chief Operating Officer
He has served in R&D capacities at Phytera, Inc., Centocor, Inc., and Becton Dickinson and Co., and as Adjunct Associate Professor of Microbiology at the University of Pennsylvania.
Related articles »  
Eric Schoenstein: High Growth Stock Picks With Quality Management
Becton, Dickinson and Company (BDX, Earnings, Analysts, Financials): Develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide.
DaVita to Cut Energy Use 15% Per Treatment by 2015
Dialysis provider DaVita Inc. plans to cut its energy consumption 15 percent per treatment by 2015 as part of a larger environmental initiative.
IPO Releases List of Top 300 Patent Holders for 2011
Life sciences companies and organizations that failed to make the IPO top 300 in 2011 after making it in 2010 included Boehringer Ingelheim International GmbH (#260 on the IPO top 300 for 2010), Becton, Dickinson and Co. (263), Columbia University (272 ...
Related articles »